Jushi Holdings (JUSHF) Cash from Operations Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 140.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140.98% |
| Mar 31, 2026 | 14.38% |
| Dec 31, 2025 | -15.42% |
| Sep 30, 2025 | 156.11% |
| Jun 30, 2025 | -134.88% |
| Mar 31, 2025 | 15.96% |
| Dec 31, 2024 | 58.66% |
| Sep 30, 2024 | -3.42% |
| Jun 30, 2024 | 182.65% |
| Mar 31, 2024 | 281.77% |
| Dec 31, 2023 | -5.73% |
| Sep 30, 2023 | 603.69% |
| Jun 30, 2023 | 43.52% |
| Mar 31, 2023 | 74.16% |
| Dec 31, 2022 | -49.53% |
| Sep 30, 2022 | 95.41% |